chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SORE THROAT; PINK EYE; HEADACHE; RIGHT EYE PAIN; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included smoker, and non alcohol consumer, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-MAY-2021 for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAY-2021, the subject experienced right eye pain. On 14-MAY-2021, the subject experienced sore throat. On 14-MAY-2021, the subject experienced pink eye. On 14-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from right eye pain, sore throat, and headache, and the outcome of pink eye was not reported. This report was non-serious.
approx 18 hrs p/vax pt eyes became fixed & teeth started chattering, t99-100 pt then had inc shaking; rushed to MD who gave pt ibuprophen & Phenobarbital; pt then had EEG no 16SEP93 doing well no further sz;
The most excruciating pain for 4 days then tapered to unable to raise my arm. Complete immobility For 4 days  still in a sling after 7 days.  I am a very fit woman without any kind of illness ever in my life. Perfect health.. white Caucasian
LT LEG RED/SWOLLEN WARM TO TOUCH 6.5 CM X 6 CM INDURATION/ERYTHEMA
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of PNEUMOVAX23 lot # K004483 expiration date 16-AUG-2015 (dose and route were not reported). No co-suspect and concomitant therapies were reported. The nurse reported that Department of Health requested glycol thermometer readings that showed improper storage of the vaccine. Doses of vaccine may have been administered to an unspecified number of patients on  unspecified dates. Nurse also stated according to the Sensitronic thermometer there had not been a temperature excursion in this refrigerator.  No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Patient called and reported sudden symptoms that "felt like a nerve thing" and a sudden facial drooping on one side.  The symptoms subsided after a few minutes.  I instructed the patient to report any additional symptoms and to seek guidance from her MD if symptoms return.  We also discussed the possibility of Bell's Palsy after COVID vaccines.
My left arm is still sore and painful and tender. It started on May 2021 my muscles from waist down were contracted and extremely painful and it's been happening every morning It happens during the day as well and itchy. Strange lesions on my skin. My bones can be seen in the flesh and even in my back. A tingly sensation from 1-4 inches long. Like my skin is splitting apart. Saw my doctor's PA via teledoctor. 3 weeks of headaches.
Varicella - Information has been received from a licensed practical nurse concerning a 12 year old caucasian female with a penicillin allergy who on 08 Mar 1996 was vaccinated with one dose of varicella virus vaccine live sc in the left thigh.  On 20 May 2000 the patient experienced chickenpox.  Medical attention was sought.  Subsequently, the patient recovered
tingling in his hand in the same side os the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administration date 13Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "tingling in his hand in the same side os the injection site".  Additional information: He has developed tingling in his hand in the same side as the injection site. It had gone down to the top of his hand, it was mild and was very mild now. He was calling because his family was very concerned.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Intense pain Left deltoid, unable to abduct beyond 30 degrees for 24 hours, intermittent numbness and tingling L hand fingers, High Fever 102 for 48 hours, myalgias and fatigue. Resolved after 48 hours
Noticed flushing, itching & headache. Pt going home, knows to call Dr if needed.
Soreness at vacination site, heaviness in arms, bruising feeling arms hurt to move, cannot sleep because of pain, I have tried icy hot, biofreeze, Advil, Benadryl with Aleve, how do I get rid of these side effects I HURT.
This spontaneous report as received from a pharmacist via publicis representative refers to a over 60 year old female patient. On 02-JUL-2014, the patient was vaccinated with ZOSTAVAX (lot #, route and dose were not reported) for vaccination. On 02-JUL-2014, the patient developed an injection site rash after administration of ZOSTAVAX. The patient stated that "the rash did not bother her". No treatment was given for the adverse event. No lab diagnostics studies were performed. On an unknown date, the patient sought medical attention by calling the pharmacy. The outcome of injection site rash after administration of ZOSTAVAX was reported as recovering/resolving. Additional information has been requested.
Information has been received from a physician concerning a male patient who on unspecified dates was vaccinated intramuscularly with 3 doses series of GARDASIL (lot # not provided). "Back in September", the patient experienced testicular pain. At the time of reporting, the patient's status was not provided. Additional information has been requested.
suspected COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality. The reporter is the patient.  A 36-year-old male patient received BNT162b2 (BNT162B2), on 30Oct2021 at 09:30 as dose 3 (booster), single (Lot number: FH8020) at the age of 35 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Chronic Kidney stones" (unspecified if ongoing), notes: Chronic Kidney stones; "higher than normal blood pressure" (unspecified if ongoing), notes: higher than normal blood pressure. The patient's concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), outcome "unknown"; DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "COVID-19". Therapeutic measures were taken as a result of suspected covid-19, drug ineffective.  Clinical course: Covid treatment received Yes. No other medication in 2 weeks . Adverse event Bitter, at times metallic, taste in mouth. Especially bad at night and during the day the taste comes and goes. At times mouth feels like it is coated in a film. Rinsing with water helps, but taste comes back. While disgusting, I am not willing to stop taking the medication as it absolutely makes me feel better. Adverse events start date: 10Jun2022. Adverse events start time: 06:00 PM.  .Follow-up attempts are completed. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 27Aug2023 to 31Aug2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300292532 same patient/ reporter, different drug/event;
Swelling and redness with itching at site of injection after employee flu vaccination.  Employee took Zyrtec and ibuprofen for 2 days post immunization for symptoms.
Narrative: 65yo male patient moved in Aug 5,2021 with the following PROBLEM list as of 8/5/2021. Seen by palliative care medicine service (SCT 07/21/2021 305824005) (ICD-10-CM Z51.5) Chronic systolic heart failure (SCT 441481004) 07/21/2021 (ICD-10-CM I50.22) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 06/21/2016 Degeneration of lumbar or lumbosacral 04/13/2015 intervertebral disc (ICD-9-CM 722.52) Osteoarthrosis, localized, not specified whether 04/17/2018 primary or secondary, involving pelvic region and thigh (SCT 396275006) (ICD-10-CM M13.89) Lack of Housing (ICD-9-CM V60.0) 05/14/2014 Benign essential hypertension (SCT 59621000) 03/04/2019 (ICD-10-CM I10.) Unspecified personality disorder (SCT 33449004) 09/10/2020 (ICD-10-CM F60.9) Other Unspecified Counseling (ICD-9-CM V65.40) 02/06/2014 Abdominal Pain of unspecified site (ICD-9-CM 01/30/2014 789.00) Alcohol dependence (SCT 66590003) (ICD-10-CM 10/19/2015 F12.20) Cannabis dependence (SCT 85005007) (ICD-10-CM 01/15/2016 F12.21) Adjustment disorder with depressed mood (SCT 01/04/2018 57194009) (ICD-10-CM F33.8) Pt died on 11/29/2021. No notes since 8/5/2021 so no information related to pt's death given. Pt had received covid vaccines on 1/29/21 & 3/5/21. This death is likely not related to the vaccinations due to the length of time from vaccine administration.
difficulty breathing; Swelling of lymph node under left armpit and left jaw.; Metal taste in mouth; fever (99.6 F); chills; sweats; muscle aches; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot Number was FH8027,e xpiry date was not reported), via an unspecified route of administration, administered in Arm Left on 15Oct2021 12:45 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included,drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was EN6207, Expiry date was not reported) via an unspecified route of administration on 14Mar2021 08:00AM, administered in Left arm as dose 1, single for covid-19 immunisation and on 04Apr2021 08:00AM patient had received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was ER8733, Expiry date was not reported) via an unspecified route of administration, administered in Left arm as dose 2, single for covid-19 immunisation. On 15Oct2021 21:00 the patient experienced difficulty breathing, swelling of lymph node under left armpit and left jaw, metal taste in mouth, fever (99.6 f), chills, sweats, muscle aches. On 15Oct2021 the patient underwent lab tests and procedures which included body temperature was 99.6 fahrenheit. Events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of difficulty breathing, swelling of lymph node under left armpit and left jaw, metal taste in mouth,fever (99.6 f),chills, sweats,muscle aches included Advil and drink water. The clinical outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
I had a migraine beginning Feb 9 AM. I have chronic migraines that almost always occur on the left side of my head, but this one was on the right side, which is unusual for me. The migraine pain was more severe than normal. I also had a stiff right jaw and eye pain primarily on the right side. I took 100 mg Imitrex in the afternoon of Feb 9 and it reduced the pain very effectively (which is also unusual for me). On Feb 10 AM, the migraine returned or a new one started. The pain was also in the right side. I took 100 mg Imitrex and it reduced the pain somewhat effectively.  The migraine pain returned Feb 11 AM and hurt on both sides of my head. I took 100 mg Imitrex this evening (Feb 11) and it is helping so far. In addition, my left arm was sore around the injection site beginning when I got the shot and stopped this morning.
This spontaneous report was received from a female consumer of unknown age reporting on herself who on 17-SEP-2011 was vaccinated with the first dose of GARDASIL (dose and route not reported) and on 05-DEC-2011 was vaccinated with the second dose of GARDASIL (dose and route not reported). No other co-suspects were reported. No concomitant medications were reported. The patient missed the third dose of GARDASIL. No adverse effect was reported. Patient's outcome was unknown. Additional information has been requested.
Pain at Tdap site starting 1 day after done and progressed to generalized aching in a few hours. Unable to reach pt since.
Constant HA, fatigue, joint pains and " hot flashes" since receiving 1st Anthrax vaccine on 04/23/2003. Present Illness: 23 year old active duty Military personnel. Although he admits to been afraid of needles, he states that he was in good health when he received his 1st anthrax vaccination. He has never had any px with previous vaccinations in the past. 04/23/03- Anthrax 1: pain at inj. site. "felt like i blew my triceps out. Some numbness and tingling down into right elbow that lasted about 1-2 days. This has since resolved completely. Severe HA across forehead, above eyes usually within 30-45 minutes of injection 9/10 on the pain scale. He medicated with Motrin 800 mg  and the pain subsided to @ 3/10. He denies aura, photo, or photophobia, numbness, or weakness. He awoke the next morning with a dull, constant HA that improves with Motrin BID bur reoccurs daily. He also complained of sharp stabbing pains that occurred 4-8 times per day lasting several minutes that immobilized him. Whenever they occurred in both knees and his right elbow. I felt like my knees needed to be popped. He medicated with icy hot with some relief. These pains have decreased to mostly a constatnt aching pain. Two days post vaccine he began having periodic "hot flashes" startig with his hears feeling hot then sweating of his face chest and back with occassional nausea lasting 20-30 minutes. These usually occur after eating and at night. The episodes have decreased in frequency at this time.
shingles outbreak/multiple shingles outbreaks; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 12-OCT-2012, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for routine health maintenance and for its intended purpose; the prevention of shingles (herpes zoster) (prophylaxis).Shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered a shingles outbreak, and had since suffered multiple shingles outbreaks which persist to the present date. As a result, her husband had suffered loss of services and society and asserts a loss of consortium claim. As a direct and proximate results of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations do not present prior to using zoster vaccine live (ZOSTAVAX). Also, experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. Also, the patient sustained severe and permanent personal injuries. Therefore, suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Also, suffered and incurred damages, including medical expenses, the loss of accumulations, and other economic and non-economic damages. The outcome of the event was not recovered.
Dizziness; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VOMITING (Vomiting) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (Dizziness) and VOMITING (Vomiting). At the time of the report, DIZZINESS (Dizziness) and VOMITING (Vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Patient received the vaccine & left the immunization room to sit in the post-vaccination waiting area. He made it to the chair & passed out into the floor. He was not unconscious for more than a few moments, but was very aggressive upon coming to. He refused to lay down, preferring to sit up. We put ice packs on him to cool him down. He denied wanting an ambulance. Pt reported feeling dizzy, confused upon awakening, thirsty, hot, and nauseous. We gave him some water & let him rest for a bit. After several minutes he wanted to sit in a chair and get off the floor & was able to with assistance. He rested for a bit more while the store management filled out an incident report. Patient was very irritable and refused to rest for any longer & left the store without assistance. Tried to call to follow up on 8/8/21 but neither patient or wife answered the phone.
Received flu vaccine 10/20/10 at approx 530AM 10/21/10 had a generalized seizure. EMS called. Eval in ED head CT negative, CXR negative.
Patient at first had lightheadedness, then became slow to respond to questions. Patient then developed chills and nausea. Patient transferred to ER for further evaluation and management.
Swollen lymph node in left armpit; Discomfort in joints; fever; This is a spontaneous report received from a contactable consumer or other non-HCP (patient reported for himself). A 48-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 at 11:00 AM (at the age of 48-year-old), as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Crustacean allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included Levothyroxine sodium (Sintroid 112) (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient previously received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 23Mar2021, as single for covid-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021, the patient experienced swollen lymph node in left armpit tennis ball sized, discomfort in joints and fever. No treatment was received for the adverse events. The events did not result into death, Life threatening, caused/prolonged hospitalization, Disabling/Incapacitating and Congenital anomaly/birth defect. The case was reported as non-serious. The patient outcome of the events was Resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient had headache and dizziness immediately post GARASIL / Tdap / MENACTRA - did not eat breakfast - gave food felt better in 30 minutes. Vitals good throughout.
(R) axillary lymphadenopathy (tender), (R) neck/jaw pain. No fever. No cough/SOB.
red itchy skin rash; red itchy skin rash; This is a spontaneous report from a contactable consumer based on information received by Pfizer from program (manufacturer control number US-AMGEN-USASP2021069724). This case was split from master case 2021537545 for an elderly patient taking bnt162b2 and experienced red itchy skin rash.  An elderly male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included ongoing rheumatoid arthritis with rheumatoid factor, unspecified. Concomitant medication(s) included etanercept (ENBREL) taken for rheumatoid arthritis from Sep2020 and ongoing; allopurinol (ALLOPURINOL); atorvastatin (ATORVASTATIN); fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA); ferrous sulfate (FERROUS SULFATE); prednisone (PREDNISONE); valsartan (VALSARTAN). The patient experienced red itchy skin rash on an unspecified date. The patient underwent lab tests and procedures which included biopsy skin: unknown results on 04May2021 to determine cause of rash whose result were not provided. No treatment information was received. Outcome of events was not resolved.  No follow-up attempts are possible. No further information is expected.
whole arm was hurting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "whole arm was hurting".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had my vaccine at 07:00pm on the 22nd of April, and exactly 12 hours after the vaccine I started to feel chills, and I was shaking and I was cold, and my teeth were shattering, I had multiple blankets and pajamas on but I was just really cold. It lasted for a few hours. Then I was sleepy non-stop, I did not eat, I slept all day long, non-stop. Sat and Sunday, it took at least 4 days for me to back to my normal self. I started having heart palpitations about a week or so after the vaccine.  I had to wear a monitor for 3 days, after that I went to the cardiologist and she was afraid that I had Afib, or stroke, and asked me to carry aspirin with me all the times, she is going to change my meds and I have an echo scheduled as well.